How do we help patients?
We discover and deliver medicines that make a remarkable impact on patients right now.
“They're dedicating their lives and their science to making the world a better place. If I were to meet the AbbVie scientists, I would just hug them.”
4M+ people a year take AbbVie medicines in the U.S.
32 conditions treated by AbbVie medicines
- Rheumatoid arthritis
- Blood cancers
- Hepatitis C
- Parkinson’s disease
- Psoriasis
- Crohn’s disease
- Endometriosis
- Ulcerative colitis
- Hypothyroidism
- Psoriatic arthritis
- Juvenile idiopathic arthritis
- Endocrine pancreatic insufficiency
- Rheumatoid arthritis
- Blood cancers
- Hepatitis C
- Parkinson’s disease
- Psoriasis
- Crohn’s disease
- Endometriosis
- Ulcerative colitis
- Hypothyroidism
- Psoriatic arthritis
- Juvenile idiopathic arthritis
- Endocrine pancreatic insufficiency
- Rheumatoid arthritis
- Blood cancers
- Hepatitis C
- Parkinson’s disease
- Psoriasis
- Crohn’s disease
- Endometriosis
- Ulcerative colitis
- Hypothyroidism
- Psoriatic arthritis
- Juvenile idiopathic arthritis
- Endocrine pancreatic insufficiency
Patient Assistance Program
“I was able to use the AbbVie patient assistance program, which was a blessing.”
Patient Assistance Program
~89,000 U.S. patients received medicine at no cost in 2019 through myAbbVie Assist patient assistance program
What does it take to invent medicines of the future?
- Tenacious discoverers.
- Explorers.
- Problem solvers.
- Optimists.
These are just some of the tough diseases we’re tackling:
- Alzheimer’s disease
- Cancer
- Parkinson’s disease
- Multiple sclerosis
- Crohn’s disease
- Atopic dermatitis
- Uterine fibroids
- Rheumatoid arthritis
$5B invested in R&D researching new medicines in 2019
72% of medicines in our pipeline considered first-in-kind
You can’t do today’s job with yesterday’s methods and be successful tomorrow.
Innovating clinical trials
40K+ patients participating in AbbVie clinical trials in the U.S.
Advancements in technology are changing how we conduct clinical trials.
Using a range of new technologies, from artificial intelligence to wearables, we can improve the efficiency and speed of clinical trials, ultimately striving to bring treatments to patients more quickly.
40K+ patients participating in AbbVie clinical trials in the U.S.
What do you get when you bring together diverse expertise and a culture to invent the future?
An inclusive environment where breakthroughs can break through.
-
Fortune’s “100 Best Companies To Work For”
-
Partnering with organizations to use large data sets to uncover insights that can improve treatment strategies for blood cancers
-
AbbVie researchers have donated nearly 40K hours of work to conduct research on neglected tropical diseases, malaria and tuberculosis
Our commitment to health doesn’t stop with our medicines.
We take our part in the global community seriously by supporting the patients we serve, the people we employ and the world we live in.
-
AbbVie employees volunteered over 68k hours in 2019
Our Week of Possibilities unites AbbVie employees around the world to make a difference, giving back to underserved communities.
-
$350M
in charitable contributions to support U.S. nonprofits in 2018
These contributions - including to Ronald McDonald House Charities, Habitat for Humanity, Direct Relief, City Year and St. Jude Children’s Research Hospital - are focused in three areas: helping families thrive, supporting disaster relief and strengthening K-12 education.
-
Partnering with nonprofits that help children facing serious illnesses and those who care for them
AbbVie has contributed $155 million to leading nonprofits working to address the unrelenting challenges faced by families of children diagnosed with a life-altering illness.